Raloxifene Hydrochloride is the hydrochloride salt form of raloxifene, a selective benzothiophene estrogen receptor modulator (SERM) with lipid lowering effects and activity against osteoporosis. Raloxifene hydrochloride specifically binds to estrogen receptors in responsive tissue, including liver, bone, breast, and endometrium. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Raloxifene HCl, Keoxifene hydrochloride, Optruma and Ostiral. Its PubChem CID is 54900.
Raloxifene hydrochloride
| CAS No | 82640-04-8 |
|---|---|
| Molecular Formula | C28H28ClNO4S |
| Molecular Weight | 510.0 g/mol |
| Synonyms | [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Raloxifene Hydrochloride is the hydrochloride salt form of raloxifene, a selective benzothiophene estrogen receptor modulator (SERM) with lipid lowering effects and activity against osteoporosis.
The listed CAS number is 82640-04-8.
The listed molecular formula is C28H28ClNO4S.
The listed molecular weight is 510.0 g/mol.
[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride.
The source lists Raloxifene HCl, Keoxifene hydrochloride, Optruma and Ostiral.